NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:NovoCure Ltd (NVCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014232
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellular carcinoma, breast cancer and small cell lung cancer, among others. It also offers products for other indications such as glioblastoma and diagnosed glioblastoma. Novocure operates along with its subsidiaries located in New Hampshire, the US; and Berlin, Germany. The company owns and operates a research centre in Haifa, Israel. It also has presence in Japan and Switzerland. NovoCure is headquartered in Jersey, the UK.

NovoCure Ltd (NVCR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
NovoCure Ltd, Medical Devices Deals, 2011 to YTD 2017 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
NovoCure Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novocure Enters into Research Agreement with MD Anderson Cancer Center 11
Equity Offering 12
NovoCure Raises USD95 Million in Public Offering of Series J Shares 12
NovoCure Raises USD194 Million in Public Offering of Series I Shares 13
NovoCure Raises USD55 Million in Public Offering of Series H Shares 14
NovoCure Raises USD44.1 Million in Public Offering of Shares 15
NovoCure Ltd – Key Competitors 16
NovoCure Ltd – Key Employees 17
NovoCure Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Oct 26, 2017: Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update 19
Jul 27, 2017: Novocure Reports Second Quarter 2017 Financial Results and Provides Company Update 22
Apr 27, 2017: Novocure Reports First Quarter 2017 Financial Results and Provides Company Update 25
Nov 02, 2016: Novocure Reports Third Quarter 2016 Financial Results and Provides Company Update 27
Jul 28, 2016: Novocure Reports Second Quarter 2016 Financial Results and Provides Company Update 30
Corporate Communications 33
May 11, 2017: Martin J. Madden Joins Novocure Board of Directors 33
May 11, 2016: Novocure Enters into Employment Agreement with William Doyle 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
NovoCure Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NovoCure Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
NovoCure Ltd, Medical Devices Deals, 2011 to YTD 2017 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novocure Enters into Research Agreement with MD Anderson Cancer Center 11
NovoCure Raises USD95 Million in Public Offering of Series J Shares 12
NovoCure Raises USD194 Million in Public Offering of Series I Shares 13
NovoCure Raises USD55 Million in Public Offering of Series H Shares 14
NovoCure Raises USD44.1 Million in Public Offering of Shares 15
NovoCure Ltd, Key Competitors 16
NovoCure Ltd, Key Employees 17
NovoCure Ltd, Other Locations 18
NovoCure Ltd, Subsidiaries 18

★海外企業調査レポート[NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LifeScan Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • EBTEC Corporation:企業の戦略・SWOT・財務分析
    EBTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary EBTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Norwegian Air Shuttle ASA:戦略・SWOT・企業財務分析
    Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report Summary Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cisco Systems, Inc (CSCO)-石油・ガス分野:企業M&A・提携分析
    Summary Cisco Systems, Inc (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products include blade switches, analytics and automation software, application networking services, interface …
  • Bartlett Holdings Inc:電力:M&Aディール及び事業提携情報
    Summary Bartlett Holdings Inc, doing business as BHI Energy, a subsidiary of AE Industrial Partners LLC, is a specialty service and staffing solutions provider. The company offers complete maintenance, radiological and professional technical staffing solutions. It provides power services including m …
  • Sonoro Energy Ltd (SNV):企業の財務・戦略的SWOT分析
    Summary Sonoro Energy Ltd (Sonoro Energy), formerly Sonic Technology Solutions Inc is an oil and gas company that explores, develops and produces asphalt and bitumen resources. It operates Budong Budong Production Sharing Contract on the coast of western Sulawesi, opposite to Balikpapan that offers …
  • Profire Energy Inc (PFIE):企業の財務・戦略的SWOT分析
    Summary Profire Energy Inc (Profire Energy) is an oilfield technology company that undertakes design, development, and installation of combustion management technology and chemical injection solutions. The company offers products such as burner management systems and chemical management systems. Its …
  • Thai Oil Public Co Ltd (TOP):企業の財務・戦略的SWOT分析
    Thai Oil Public Co Ltd (TOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Japan Airport Terminal Co Ltd:企業の戦略・SWOT・財務分析
    Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airport Terminal Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Municipal Energy Agency of Nebraska:発電所・企業SWOT分析
    Municipal Energy Agency of Nebraska – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Enel Americas SA:企業の戦略・SWOT・財務情報
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sojitz Corporation:企業の戦略・SWOT・財務分析
    Sojitz Corporation - Strategy, SWOT and Corporate Finance Report Summary Sojitz Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Genalyte Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genalyte Inc (Genalyte) is a lab testing service provider. The company’s services include data analysis, phlebotomist for blood draw, integration with existing emr, phlebotomist for blood draw, applications for test order and results review and clinical lab scientist. It provides instruments …
  • Population Genetics Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Population Genetics Technologies Ltd (Population Genetics) is a biotechnology company that offers diagnostic test solutions. The company provides products such as diagnostic test kits, HIV diagnostic test systems, and HCV diagnostic test systems. Its diagnostic test kits provide reagent assa …
  • Identiv Inc (INVE):企業の財務・戦略的SWOT分析
    Summary Identiv Inc (Identiv), formerly Identive Group Inc, is a technology company that offers physical security and secure identification solutions. The company’s products include trusted authentication solutions, identity solutions, physical access control solutions, premises access solutions, co …
  • Eni SpA (ENI)-エネルギー分野:企業M&A・提携分析
    Summary Eni S.p.A. (Eni) is an integrated oil and gas company, which carries out oil and natural gas exploration, field development and production activities. It also involves in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company manages developed and undeveloped ac …
  • Delaware Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Delaware Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Tokio Marine Asia Pte. Ltd.:企業の戦略・SWOT・財務情報
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆